Advertisement

Topics

BRIEF-Novo submits label application in the US for insulin drug Tresiba

04:41 EDT 23 Sep 2016 | Reuters

* Says has submitted a supplemental application to the US Food and Drug Administration (FDA) for including results from its two SWITCH trials in insulin drug Tresiba's label

Original Article: BRIEF-Novo submits label application in the US for insulin drug Tresiba

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Novo submits label application in the US for insulin drug Tresiba"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...